Wafik S. El-Deiry: Excited about the impact of advocacy work in Rhode Island

Wafik S. El-Deiry posted the following on LinkedIn:

“Excited about the impact of advocacy work in Rhode Island and looking forward to seeing much more in the future with the Rhode Island Oncology Society in its role as an ASCO State Affiliate.

The Legorreta Cancer Center has been active in advocacy and policy work for several years at the State and Federal levels to make life better for Rhode Islanders.

There is a heavy burden from cancer in the state across cancer types.

Our partners include Association of American Cancer Institutes, AACR, American Cancer Society, ACS CAN, Legorreta Cancer Center, Brown University, ASCO, Rob Winn, Margaret Foti, Karen Knudsen, Stephanie Graff, Don S. Dizon, Kimryn Rathmell, Sheldon L. Holder, Roxanne Wood, Mia Ackerman, Gabe Amo.”

Source: Wafik S. El-Deiry/X

Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals. He is the Editor in Chief at Oncotarget.

Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.